Clinical trial

Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity

NCT03003572

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Blood samples Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2018-03-27

PhaseN/A

Conditions

Primary Sjögren's Syndromeunresolved

Interventions

Blood samplesOTHER

Sponsors & collaborators

Centre Hospitalier Universitaire de Saint Etiennelead sponsor

Ministry of Health, Francecollaborator

Mapped research locations

LyonFrance3 Clermont-FerrandFrance1 GrenobleFrance1 ReimsFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03003572 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.